More Life (A42J37) Stock Overview
A biotech company, focuses on advancing solutions to optimize human, animal, and plant health in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
A42J37 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
The More Life Company Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.038 |
| 52 Week High | CA$0.052 |
| 52 Week Low | CA$0.0002 |
| Beta | -2.72 |
| 1 Month Change | -9.52% |
| 3 Month Change | -19.15% |
| 1 Year Change | 3,700.00% |
| 3 Year Change | 167.61% |
| 5 Year Change | -85.04% |
| Change since IPO | -51.90% |
Recent News & Updates
Recent updates
Shareholder Returns
| A42J37 | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -5.0% | 0.9% | -0.6% |
| 1Y | 3,700.0% | 38.6% | 2.7% |
Return vs Industry: A42J37 exceeded the German Pharmaceuticals industry which returned 41.2% over the past year.
Return vs Market: A42J37 exceeded the German Market which returned 2.4% over the past year.
Price Volatility
| A42J37 volatility | |
|---|---|
| A42J37 Average Weekly Movement | 21.8% |
| Pharmaceuticals Industry Average Movement | 5.3% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in DE Market | 12.9% |
| 10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: A42J37's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: A42J37's weekly volatility has decreased from 284% to 22% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Dennis Hancock | www.themorelife.company |
The More Life Company Corp., a biotech company, focuses on advancing solutions to optimize human, animal, and plant health in Canada. The company offers Quicksome which uses proprietary formulations and stabilizing agents to encapsulate active ingredients and optimizing delivery in pharmaceutical and nutraceutical applications; and Quicksol that enhances solubility for previously insoluble macrocyclic lactone drugs. It also provides licensed Agrarius, an agricultural plant signalling technology.
The More Life Company Corp. Fundamentals Summary
| A42J37 fundamental statistics | |
|---|---|
| Market cap | €17.05m |
| Earnings (TTM) | -€1.74m |
| Revenue (TTM) | €40.42k |
Is A42J37 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A42J37 income statement (TTM) | |
|---|---|
| Revenue | CA$65.00k |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$65.00k |
| Other Expenses | CA$2.86m |
| Earnings | -CA$2.79m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0061 |
| Gross Margin | 100.00% |
| Net Profit Margin | -4,300.00% |
| Debt/Equity Ratio | -285.8% |
How did A42J37 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/08/21 15:59 |
| End of Day Share Price | 2026/08/20 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
The More Life Company Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.